Keefe, Bruyette & Woods analyst Ryan Lynch maintains Fidus Investment (NASDAQ:FDUS) with a Market Perform and lowers the price target from $20.5 to $20.
Fidus Inv (NASDAQ:FDUS) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.49 by 4.08 percent. This is a 4.08 percent increase over earnings of $0.49 per share from the same
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Fidus Investment (NASDAQ:FDUS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.